March 2009 Volume 6 Number 3
Visit Nature Clinical Practice Cardiovascular Medicine online to browse
the journal.
Now available at http://links.ealert.nature.com/ctt?kn=48&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
================ Important information - please read ================
Note: Starting with the April 2009 e-Alert, Nature Clinical Practice
Cardiovascular Medicine will change its name to Nature Reviews
Cardiology. No action is required on your part; you will continue
to receive this e-Alert each month. However, in compliance with our
data protection practices, we need to inform you that the sender's
email address will change from
NCP_Cardiovascular_Medicine@ealert.nature.com to
Nature_Reviews_Cardiology@ealert.nature.com
=====================================================================
Journal of Perinatology continues to impact the work of researchers
and the lives of neonates for nearly 30 years.
Journal of Perinatology delivers original articles, clinical reviews,
and research reports on the latest findings in neonatology, covering:
- Maternal and fetal medicine
- The neonatal period
- The follow-up of the infant and child
Visit http://links.ealert.nature.com/ctt?kn=57&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
to view the latest research and gain open access to timely and popular
articles throughout the year.
=====================================================================
----------------------
EDITORIAL
----------------------
JUPITER strikes earth
Valentin Fuster and Sameer Bansilal
http://links.ealert.nature.com/ctt?kn=13&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
----------------------
RESEARCH HIGHLIGHTS
----------------------
C-reactive protein: a predictive marker, not a causal factor, for
cardiovascular disease
http://links.ealert.nature.com/ctt?kn=27&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Fondaparinux: a promising alternative to heparin treatment for acute
coronary syndromes
http://links.ealert.nature.com/ctt?kn=32&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Atrial fibrillation: oral anticoagulation therapy or antiplatelet therapy?
http://links.ealert.nature.com/ctt?kn=63&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Low-density lipoprotein receptor gene mutations diagnose familial
hypercholesterolemia
http://links.ealert.nature.com/ctt?kn=3&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Decline in ankle-brachial index is associated with increased risk of
cardiovascular events
http://links.ealert.nature.com/ctt?kn=61&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Older patients represent a distinct clinical subgroup in infective
endocarditis
http://links.ealert.nature.com/ctt?kn=72&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Vitamin C and E supplements do not reduce the risk of cardiovascular
events in men
http://links.ealert.nature.com/ctt?kn=17&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Chlorthalidone is best for preventing heart failure in patients with
hypertension
http://links.ealert.nature.com/ctt?kn=58&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
----------------------
CLINICAL ADVANCES
----------------------
Is intravenous recombinant plasminogen activator effective up to 4.5 h
after onset of ischemic stroke?
Peter M Rothwell
http://links.ealert.nature.com/ctt?kn=2&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
The emerging role of cardiovascular magnetic resonance in refining the
diagnosis of hypertrophic cardiomyopathy
James C Moon and William J McKenna
http://links.ealert.nature.com/ctt?kn=55&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Primary prevention of cardiovascular events in diabetes: is there a role
for aspirin?
Hermione C Price and Rury R Holman
http://links.ealert.nature.com/ctt?kn=83&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
----------------------
VIEWPOINTS
----------------------
How important are health systems in the prevention of cardiovascular
and other noncommunicable diseases?
Sania Nishtar
http://links.ealert.nature.com/ctt?kn=65&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
The Marfan aortic root: time to refine surgical guidelines
Stephen Westaby
http://links.ealert.nature.com/ctt?kn=30&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
----------------------
REVIEWS
----------------------
Diagnosis and management of atherosclerotic renal artery stenosis:
improving patient selection and outcomes
Christopher J White and Jeffrey W Olin
http://links.ealert.nature.com/ctt?kn=36&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
The role of interleukin 18 in the pathogenesis of hypertension-induced
vascular disease
Simon W Rabkin
http://links.ealert.nature.com/ctt?kn=79&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Noninvasive imaging of atheromatous carotid plaques
Umar Sadat, Zhi-Yong Li, Martin J Graves, Tjun Y Tang and Jonathan H Gillard
http://links.ealert.nature.com/ctt?kn=8&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
----------------------
CASE STUDIES
----------------------
Emergency surgical treatment of advanced endomyocardial fibrosis in
Mozambique
Ana Olga Mocumbi, Carla Carrilho, Margaret M Burke, Gavin Wright and
Magdi H Yacoub
http://links.ealert.nature.com/ctt?kn=22&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Antiphospholipid antibodies from a patient with primary antiphospholipid
syndrome enhance experimental atherosclerosis
Arnon Adler, Arnon Afek, Yair Levy, Gad Keren and Jacob George
http://links.ealert.nature.com/ctt?kn=35&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
----------------------
CLINICAL RESEARCH
----------------------
Cross-sectional, prospective study of MRI reproducibility in the
assessment of plaque burden of the carotid arteries and aorta
Hamza El Aidi, Venkatesh Mani, Karen B Weinshelbaum, Silvia H Aguiar,
Hiroaki Taniguchi, John E Postley, Daniel D Samber, Emil I Cohen,
Jessica Stern, Rob J van der Geest, Johan HC Reiber, Mark Woodward,
Valentin Fuster, Samuel S Gidding and Zahi A Fayad
http://links.ealert.nature.com/ctt?kn=28&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Longitudinal cohort study on the effectiveness of lipid apheresis
treatment to reduce high lipoprotein(a) levels and prevent major adverse
coronary events
Beate R Jaeger, Yvonne Richter, Dorothea Nagel, Franz Heigl, Anja Vogt,
Eberhard Roeseler, Klaus Parhofer, Wolfgang Ramlow, Michael Koch, Gerd
Utermann, Carlos A Labarrere and Dietrich Seidel, for the Group of
Clinical Investigators
http://links.ealert.nature.com/ctt?kn=75&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Use of arginine-glycine-aspartic acid adhesion peptides coupled with a
new collagen scaffold to engineer a myocardium-like tissue graft
Olivier Schussler, Catherine Coirault, Mariana Louis-Tisserand, Walid
Al-Chare, Patricia Oliviero, Claudine Menard, Robert J Michelot, Pascal
Bochet, Daniel R Salomon, Juan C Chachques, Alain Carpentier and
Yves Lecarpentier
http://links.ealert.nature.com/ctt?kn=21&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Concurrent upregulation of endogenous proapoptotic and antiapoptotic
factors in failing human hearts
Nezam Haider, Eloisa Arbustini, Sudhir Gupta, Han Liu, Navneet Narula,
Roger Hajjar, Narain Moorjani, Stephen Westaby, Marc J Semigran, G William
Dec, Y Chandrashekhar and Jagat Narula
http://links.ealert.nature.com/ctt?kn=59&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
----------------------
ARTICLE RESPONSES
----------------------
C-reactive protein and severity of coronary allograft vasculopathy
Carlos A Labarrere, John R Woods, Miguel A Ortiz and Gonzalo L Campana
http://links.ealert.nature.com/ctt?kn=1&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Author's response to "C-reactive protein and severity of coronary
allograft vasculopathy"
Giovanna Sarno and Marc Vanderheyden
http://links.ealert.nature.com/ctt?kn=82&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Mild increase in coronary sinus pressure with coronary sinus reducer
stent for treatment of refractory angina
Yoav Paz and Amihay Shinfeld
http://links.ealert.nature.com/ctt?kn=51&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
Coronary venous pressure elevation 'risks and benefit'
Werner Mohl, Dejan Milasinovic and Gunter Steurer
http://links.ealert.nature.com/ctt?kn=42&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
=====================================================================
In April 2009 Nature Clinical Practice Rheumatology will become Nature
Reviews Rheumatology, with a new look and additional content.
For more information visit:
http://links.ealert.nature.com/ctt?kn=12&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=29&m=31644431&r=MTc2NDI1MzEzNAS2&b=2&j=NDYwMzM0NDUS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact our customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
=====================================================================
